Cincinnati Children's Hospital Medical Center

• by EVOMT
• 2020-03-19

Cincinnati Children's Hospital Medical Center is a non-profit pediatric academic medical center that serves as a medical center. In the 2018-2019 honor list of the top ten children's hospitals in the United States published by US News and World Report, the comprehensive ranking is second, and the pediatric oncology category ranks first. Among the top ten pediatric specialist fields evaluated, Cincinnati Children's Hospital is among the best children's hospitals in the United States. The hospital currently has 13852 employees and 598 beds. Its advantageous disciplines include the Cancer and Hematology Research Institute, Neurology and Neurosurgery, Nephrology, and Heart Research Institute. In 2017, the number of patients exceeded 1.3 million, serving patients from 50 states and 58 countries in the United States, including 589 international patients. Among children's hospitals in the United States, this hospital is the third hospital to receive the highest amount of pediatric research funding from the National Institutes of Health.

The Cincinnati Children's Hospital Medical Center is one of the top hospitals funded by the National Institutes of Health, dedicated to helping children around the world treat rare or complex diseases. Here, we not only have a highly skilled medical team and sophisticated hardware and software facilities, but also have complete systems and service concepts. From the care of the fetus during pregnancy to the care of newborns, to the treatment of complex and rare diseases in children, the Cincinnati Children's Hospital Medical Center can provide world-class treatment and care.

The Cincinnati Children's Hospital Medical Center is also a member of the four leading cancer research groups in the United States, and is the only children's hospital in the United States with this qualification, with outstanding results in the treatment of leukemia, brain tumors, and other cancers. The center is the first hospital to treat autoimmune lymphocytic syndrome using bone marrow transplantation. The center is the first to develop cutting-edge therapies for treating rare, recurrent, and high-risk cancers. The Fanconi Anemia Comprehensive Cancer Center of the center is the first Fanconi Anemia Comprehensive Cancer Center in the United States and one of the largest Fanconi Anemia Comprehensive Cancer Centers in the world.